PURE Bioscience Receives FDA Approval for PURE Hard Surface Disinfectant

SAN DIEGO--(BUSINESS WIRE)--PURE Bioscience, Inc. (NASDAQ: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today announced that Health Canada has approved PURE™ Hard Surface disinfectant for use in food premises, hospitals and health care facilities, domestic locations and institutional and industrial premises. PURE Hard Surface has been assigned the Drug Identification Number (DIN) 02368803.